-
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella...
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity – 2020. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - Table I. infrequently reported notifiable diseases
NNDSS - Table I. infrequently reported notifiable diseases - 2017. In this Table, provisional cases of selected infrequently reported notifiable diseases (<1,000 cases... -
NNDSS - Table I. infrequently reported notifiable diseases
NNDSS - Table I. infrequently reported notifiable diseases - 2018. In this Table, provisional cases of selected infrequently reported notifiable diseases (<1,000 cases... -
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella...
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity – 2022. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - Table I. infrequently reported notifiable diseases
NNDSS - Table I. infrequently reported notifiable diseases - 2017. In this Table, provisional cases of selected infrequently reported notifiable diseases (<1,000 cases... -
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella...
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity – 2020. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - Table I. infrequently reported notifiable diseases
NNDSS - Table I. infrequently reported notifiable diseases - 2018. In this Table, provisional cases of selected infrequently reported notifiable diseases (<1,000 cases... -
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella mo...
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella...
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity – 2022. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella mo...
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella mo...
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella...
NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity – 2022. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - Table I. infrequently reported notifiable diseases
NNDSS - Table I. infrequently reported notifiable diseases - 2018. In this Table, provisional cases of selected infrequently reported notifiable diseases (<1,000 cases... -
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella mo...
NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United... -
NNDSS - Table I. infrequently reported notifiable diseases
NNDSS - Table I. infrequently reported notifiable diseases - 2017. In this Table, provisional cases of selected infrequently reported notifiable diseases (<1,000 cases...